Literature DB >> 7483287

Sequence and phylogenetic analysis of the VP1 gene in two cell culture-adapted HAV strains from a unique pathogenic isolate.

C Argentini1, E D'Ugo, R Bruni, R Gluck, R Giuseppetti, M Rapicetta.   

Abstract

The nucleotide sequences of the VP1 coding region of two newly characterized, cell culture-adapted hepatitis A virus (HAV) strains (RG-SB11 and RG-SB16) were analyzed and compared with homologous regions of previously characterized HAV strains of human or monkey origin, and at different levels of tissue-culture adaptation. In particular, HM175wt and its derivative strains and MBB, LCDC1, PA21, and AGM27 isolates were considered. RG-SB11 and RG-SB16 HAV strains were derived from a pathogenic isolate from an acutely infected patient, purified from stool, and subjected to different strategies of adaptation. Several nucleotide differences were observed, but high conservation was found in the predicted VP1 protein sequences, which confirms structural constraints for this region. Furthermore, comparative amino-acid sequence analysis of VP1 from all HAV isolates studied has shown, particularly for those from naturally infected monkeys, that differences are limited to the amino and carboxy-terminal part of the molecule. The results of phylogenetic analysis have confirmed the common origin of the RG-SB11 and RG-SB16 strains. The complete nucleotide sequences of the VP1 coding region of the RG-SB11/16, HM175 derivative strains and of other HAV strains has shown that branch-length evolution can give a measure of the evolution of HAV during adaptation processes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7483287     DOI: 10.1007/bf01724295

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  21 in total

1.  Structure of poliomyelitis virus.

Authors:  J T FINCH; A KLUG
Journal:  Nature       Date:  1959-06-20       Impact factor: 49.962

2.  The entire nucleotide sequence of the genome of human hepatitis A virus (isolate MBB).

Authors:  A V Paul; H Tada; K von der Helm; T Wissel; R Kiehn; E Wimmer; F Deinhardt
Journal:  Virus Res       Date:  1987-08       Impact factor: 3.303

3.  Structure of a human common cold virus and functional relationship to other picornaviruses.

Authors:  M G Rossmann; E Arnold; J W Erickson; E A Frankenberger; J P Griffith; H J Hecht; J E Johnson; G Kamer; M Luo; A G Mosser
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

4.  Molecular epidemiology of HIV transmission in a dental practice.

Authors:  C Y Ou; C A Ciesielski; G Myers; C I Bandea; C C Luo; B T Korber; J I Mullins; G Schochetman; R L Berkelman; A N Economou
Journal:  Science       Date:  1992-05-22       Impact factor: 47.728

5.  Characteristics of a human diploid cell designated MRC-5.

Authors:  J P Jacobs; C M Jones; J P Baille
Journal:  Nature       Date:  1970-07-11       Impact factor: 49.962

6.  Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication.

Authors:  R W Jansen; J E Newbold; S M Lemon
Journal:  Virology       Date:  1988-04       Impact factor: 3.616

7.  Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response.

Authors:  V Gauss-Müller; M Q Zhou; K von der Helm; F Deinhardt
Journal:  J Med Virol       Date:  1990-08       Impact factor: 2.327

8.  Characterization of a simian hepatitis A virus (HAV): antigenic and genetic comparison with human HAV.

Authors:  E A Brown; R W Jansen; S M Lemon
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.

Authors:  E A Emini; J V Hughes; D S Perlow; J Boger
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies.

Authors:  L H Ping; S M Lemon
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.